AdrienneEShapiroMD, PhD(She/Her)

HIV/AIDS Medicine, Mycobacterial Disease

Assistant Professor, Global Health and Infectious Diseases

Dr. Shapiro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a board-certified infectious diseases specialist and internal medicine physician. I have a primary care HIV clinic and attend on inpatient general medicine and infectious diseases consult services.

University of WashingtonFellowship, Infectious Disease, 2015 - 2019
University of California (San Francisco)Residency, Internal Medicine, 2013 - 2015
Johns Hopkins University School of MedicineClass of 2013

PubMed

645 citations
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya
The New England Journal of Medicine. 2021-10-27
174 citations
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya
JAMA. 2022-04-05
167 citations
The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review.
Katharina Kranzer, Hoviyeh Afnan-Holmes, Keith Tomlin, Jonathan E. Golub, Adrienne E Shapiro
The International Journal of Tuberculosis and Lung Disease. 2013-04-01

What You Need to Know About COVID-19 VaccinesOctober 29th, 2021
Monoclonal Antibody Treatment Highly Effective at Reducing COVID-19 HospitalizationsOctober 28th, 2021
Researchers Identify Antibodies That Could Be Protective Against Multiple Sarbecoviruses, Including SARS-CoV-2 and Its VariantsOctober 13th, 2021